Angiogenesis and cancer stem cells: New perspectives on therapy of ovarian cancer

被引：64
|
作者：
Markowska, Anna [1 ]
Sajdak, Stefan [2 ]
Markowska, Janina [3 ]
Huczynski, Adam [4 ]
机构：
[1] Karol Marcinkowski Med Univ, Dept Perinatol & Womens Dis, Poznan, Poland
[2] Karol Marcinkowski Med Univ, Dept Gynecol Surg, Poznan, Poland
[3] Karol Marcinkowski Med Univ, Dept Oncol, Poznan, Poland
[4] Adam Mickiewicz Univ, Fac Chem, Poznan, Poland
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2017年 / 142卷
关键词：
Ovarian cancer; Cancer stem cells; Anti-angiogenic therapy; Metformin; Salinomycin; IN-VITRO; TUMOR ANGIOGENESIS; TARGETED TREATMENT; DRUG-RESISTANCE; METFORMIN; SALINOMYCIN; APOPTOSIS; CYTOTOXICITY; BEVACIZUMAB; MECHANISMS;
D O I：
10.1016/j.ejmech.2017.06.030
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Failure in ovarian cancer therapy, following cytoreduction and chemotherapy, is related to the presence of cancer stem cells - a small subpopulation of cells resistant to chemotherapy and irradiation - in the tumour which may cause cancer relapse and manifestation of metastases. Therapies targeted at Cancer Stem Cells (CSCs), such as those employing metformin (a drug used in the treatment of diabetes type II) and salinomycin, an antibiotic isolated from Streptococcus calms bacteria, seem promising. Antiangiogenic therapy with bevacizumab was found to be effective in all phases of ovarian cancer treatment. The presence of CSCs has been associated with angiogenesis. Several CSC biomarkers correlate with the markers of angiogenesis and some signalling pathways, e.g. Notch, and are used by both CSCs and by pro-angiogenic factors. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：87 / 94
页数：8
相关论文
共 50 条
  • [1] Ovarian Cancer Stem Cells: A New Target for Cancer Therapy
    Zhan, Qinglei
    Wang, Chunmei
    Saiming Ngai
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [2] Role of Cancer Side Population Stem Cells in Ovarian Cancer Angiogenesis
    Pan, Yue
    Yang, Xuefen
    Chen, Miaojuan
    Shi, Kun
    Lyu, Yuan
    Meeson, Annette P.
    Lash, Gendie E.
    MEDICAL PRINCIPLES AND PRACTICE, 2024, 33 (05) : 403 - 413
  • [3] Cancer stem cells: the theory and perspectives in cancer therapy
    Gil, Justyna
    Stembalska, Agnieszka
    Pesz, Karolina A.
    Sasiadek, Maria M.
    JOURNAL OF APPLIED GENETICS, 2008, 49 (02) : 193 - 199
  • [4] Cancer stem cells: the theory and perspectives in cancer therapy
    Justyna Gil
    Agnieszka Stembalska
    Karolina A. Pesz
    Maria M. Sąsiadek
    Journal of Applied Genetics, 2008, 49 : 193 - 199
  • [5] New perspectives on targeted therapy in ovarian cancer
    Coward, Jermaine I. G.
    Middleton, Kathryn
    Murphy, Felicity
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2015, 7 : 189 - 203
  • [6] Ovarian cancer stem cells and targeted therapy
    Vahideh Keyvani
    Moein Farshchian
    Seyed-Alireza Esmaeili
    Hadi Yari
    Meysam Moghbeli
    Seyed-Reza Kazemi Nezhad
    Mohammad Reza Abbaszadegan
    Journal of Ovarian Research, 12
  • [7] Ovarian cancer stem cells and targeted therapy
    Keyvani, Vahideh
    Farshchian, Moein
    Esmaeili, Seyed-Alireza
    Yari, Hadi
    Moghbeli, Meysam
    Nezhad, Seyed-Reza Kazemi
    Abbaszadegan, Mohammad Reza
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (01)
  • [8] Cancer stem cells: therapeutic implications and perspectives in cancer therapy
    Han, Lu
    Shi, Sanjun
    Gong, Tao
    Zhang, Zhirong
    Sun, Xun
    ACTA PHARMACEUTICA SINICA B, 2013, 3 (02) : 65 - 75
  • [9] Ovarian cancer stem cells (OCSCs): Therapy for advanced chemoresistant ovarian cancer.
    Sengupta, Prattusha
    Gangopadhyay, Sudeshna
    Sengupta, Saubhik
    Ray, Ujjal Kanti
    Mukhopadhyay, Ashis
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Cancer stem cells and angiogenesis
    Yang, Yanru
    Guo, Jingyu
    Li, Mingyang
    Chu, Guangxin
    Jin, Hai
    Ma, Jing
    Jia, Qingge
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 253
12345